Clinical Report: Anesthetic Approaches During Pediatric Heart Transplantation
Overview
This study analyzes perioperative anesthesia management and outcomes in 27 pediatric heart transplant recipients. Key findings include a survival rate of 85.2% and significant complications such as hypoxic-ischemic encephalopathy and acute kidney injury.
Background
Pediatric heart transplantation is a critical intervention for end-stage heart disease in children, yet it poses unique anesthetic challenges due to physiological variability. Understanding perioperative management strategies is essential for improving outcomes in this high-risk population. This study contributes valuable insights into real-world practices and outcomes in pediatric heart transplantation.
Data Highlights
Characteristic
Value
Number of Patients
27
Male
13
Female
14
Age Range
6 months to 16 years
Mean CPB Time
183.3 ± 55.6 min
Mean Cold Ischemia Time
249.5 ± 101.1 min
Postoperative ECMO Required
11 (40.7%)
Survival Rate
85.2%
Key Findings
Most patients (74.1%) had dilated cardiomyopathy as the primary diagnosis.
Preoperative ECMO support was utilized in 55.6% of patients.
No major cardiovascular events occurred during induction or pre-CPB.
Postoperative complications included hypoxic-ischemic encephalopathy (n = 4) and acute kidney injury requiring CRRT (n = 5).
The median LVEF was 28.5% at baseline.
Clinical Implications
Anesthesia management for pediatric heart transplantation should incorporate low-dose staged induction and invasive monitoring. Multidisciplinary collaboration is crucial to address the complex needs of this patient population and to mitigate risks associated with pulmonary hypertension and multi-organ complications.
Conclusion
The findings underscore the importance of tailored perioperative strategies in pediatric heart transplantation, highlighting the need for further research to validate these approaches in larger cohorts.
